Publicité
Publicité
LTRN
Lantern Pharma Inc. Common Stock
3.41
USDSponsorisé
-0.04
-1.16%
07 janv., 15:58 UTC -5
Fermé
Après-marché
3.46
+0.05
+1.44%
LTRN Rapports sur les bénéfices
Ratio de surprise positive
LTRN a dépassé 16 des 21 dernières estimations.
76%
Prochain rapport
Date du prochain rapport
25 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.46
Variation implicite de Q3 25 (Revenue/ EPS)
--
/+17.95%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-14.81%
Lantern Pharma Inc. Common Stock earnings per share and revenue
On 12 nov. 2025, LTRN reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.47 USD, resulting in a 18.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an hausse of 17.95% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were Lantern Pharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lantern Pharma Inc. Common Stock reported EPS of -$0.39, beating estimates by 18.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Lantern Pharma Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.57%, changed from $3.48 before the earnings release to $3.46 the day after.
When is Lantern Pharma Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 mars 2026.
What are the forecasts for Lantern Pharma Inc. Common Stock's next earnings report?
Based on 3
analystes, Lantern Pharma Inc. Common Stock is expected to report EPS of -$0.46 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité